Simone E. Muenst

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Multi-modal AI for comprehensive breast cancer prognostication.

Multi-modal AI for comprehensive breast cancer prognostication.

Journal: Nature communications
Published: May 05, 2025

Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).

Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 02, 2025

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

Journal: Nature communications
Published: March 09, 2025

Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer.

Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer.

Journal: EMBO molecular medicine
Published: March 03, 2025

Evaluating an RNA-based test for proliferation assessment and recurrence prediction in early HR+/HER2- breast cancer.

Evaluating an RNA-based test for proliferation assessment and recurrence prediction in early HR+/HER2- breast cancer.

Journal: Pathology oncology research : POR
Published: February 27, 2025

Impact of Positive Lymph Nodes after Systematic Perihilar Lymphadenectomy in Colorectal Liver Metastases.

Impact of Positive Lymph Nodes after Systematic Perihilar Lymphadenectomy in Colorectal Liver Metastases.

Journal: Journal of clinical medicine
Published: July 18, 2024

Immuno-Activated, Highly Expressing PD-1 Phenotype in Hepatocellular Carcinoma Is Associated with a Lower Recurrence Rate.

Immuno-Activated, Highly Expressing PD-1 Phenotype in Hepatocellular Carcinoma Is Associated with a Lower Recurrence Rate.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: May 15, 2024

BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors.

BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors.

Journal: Breast cancer research and treatment
Published: November 30, 2023

Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.

Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.

Journal: Journal of mammary gland biology and neoplasia
Published: October 24, 2023

Anatomic versus non-anatomic liver resection for hepatocellular carcinoma-A European multicentre cohort study in cirrhotic and non-cirrhotic patients.

Anatomic versus non-anatomic liver resection for hepatocellular carcinoma-A European multicentre cohort study in cirrhotic and non-cirrhotic patients.

Journal: Cancer medicine
Published: September 04, 2023

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.

Journal: JAMA surgery
Published: July 19, 2023

The short- and long-term outcome after the surgical management of common bile duct stones in a tertiary referral hospital.

The short- and long-term outcome after the surgical management of common bile duct stones in a tertiary referral hospital.

Journal: Langenbeck's archives of surgery
Published: March 18, 2023
Showing 1-12 of 55

Last Updated: 09/26/2026